Literature DB >> 7715747

Pulmonary uptake of bupivacaine in isolated perfused rat lung.

H Foth1, W P Geng, N Krug, F Vetterlein.   

Abstract

The ability of rat lung to remove the local anaesthetic drug bupivacaine from the blood was studied in isolated organs which were perfused either in an open (single-pass mode) or in a closed system (recirculating medium). Isolated perfused rat lungs exhibited a very low capacity to metabolize bupivacaine within 3 h during which the drug circulated continuously through the organ. The clearance values differed only by 0.2 ml/min from the control parameters in sham perfusions. The calculated extraction ratio was 0.2% and the elimination half-life was about 210 min. The volume of distribution of bupivacaine was 133 ml which remarkably surmounted the reference values obtained for sham perfusions. The distribution of bupivacaine into the pulmonary tissue was investigated applying the multiple indicator dilution technique to isolated lungs perfused in the single-pass mode. The mean elimination time of model compounds for distribution into the intravascular space, 14C-insulin, and the total water space, 3H-water, were 68 and 75 s at a flow rate of 6 ml/min. The volume of distribution was 5.9 ml for inulin and 6.5 ml for water. The mean transit time for concomitantly injected bupivacaine was 221 s and the volume of distribution was 14.4 ml. The respective parameters of sham perfusions performed without an isolated organ were substantially lower, i.e. mean elimination time 50, 50 and 61 s and distribution volume 4.9, 5.0 and 6.1 ml for inulin, water and bupivacaine.2+ f1p4

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715747     DOI: 10.1007/bf00169070

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

2.  Protein binding of prilocaine in human plasma: influence of concentration, pH and temperature.

Authors:  B Bachmann; J Biscoping; E Sinning; G Hempelmann
Journal:  Acta Anaesthesiol Scand       Date:  1990-05       Impact factor: 2.105

3.  Sensitive determination of bupivacaine in human plasma by high-performance liquid chromatography.

Authors:  H C Michaelis; W P Geng; G F Kahl; H Foth
Journal:  J Chromatogr       Date:  1990-04-27

Review 4.  Lipidosis induced by amphiphilic cationic drugs.

Authors:  H Lüllmann; R Lüllmann-Rauch; O Wassermann
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

Review 5.  The pulmonary uptake, accumulation, and metabolism of xenobiotics.

Authors:  J R Bend; C J Serabjit-Singh; R M Philpot
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

6.  Pharmacokinetic aspects of intravenous regional anesthesia.

Authors:  G T Tucker; R A Boas
Journal:  Anesthesiology       Date:  1971-06       Impact factor: 7.892

7.  Effect of prolonged desmethylimipramine administration on the pulmonary clearance of 5-hydroxytryptamine and beta-phenylethylamine in rats.

Authors:  R F Minchin; H E Barber; K F Ilett
Journal:  Drug Metab Dispos       Date:  1982 Jul-Aug       Impact factor: 3.922

8.  Pulmonary extraction of [3H]bupivacaine: modification by dose, propranolol and interaction with [14C]5-hydroxytryptamine.

Authors:  P Rothstein; J S Cole; B R Pitt
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

9.  Bupivacaine for intercostal nerve blocks in children: blood concentrations and pharmacokinetics.

Authors:  P Rothstein; G R Arthur; H S Feldman; G S Kopf; B G Covino
Journal:  Anesth Analg       Date:  1986-06       Impact factor: 5.108

10.  Lung uptake of lidocaine in man as influenced by anaesthesia, mepivacaine infusion or lung insufficiency.

Authors:  L Jorfeldt; D H Lewis; J B Löfström; C Post
Journal:  Acta Anaesthesiol Scand       Date:  1983-02       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.